A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

Novel immunotherapeutic approaches to glioma

Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens

Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate